Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000221137 | SCV000279066 | uncertain significance | not provided | 2016-10-21 | criteria provided, single submitter | clinical testing | This variant is denoted MLH1 c.-21C>T, and describes a nucleotide substitution 21 base pairs upstream of the MLH1 ATG translational start site in the 5' untranslated region (UTR). The surrounding sequence, with the base that is substituted in braces, is TTTC[C/T]TTGG. MLH1 c.-21C>T has not, to our knowledge, been reported in the literature. Although this variant does not appear to affect the start codon or the Kozak translational consensus sequence, constitutional epigenetic silencing of MLH1 has been suggested as an alternate mechanism responsible for Lynch syndrome and variants located within the 5' UTR have been shown to result in allele specific promoter methylation and subsequent transcriptional silencing (Hitchins 2011, Ward 2013). This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. The cytosine base at this position is not conserved. Based on the currently available evidence, we consider MLH1 c.-21C>T to be a variant of uncertain significance. |
Myriad Genetics, |
RCV003316233 | SCV004020269 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2023-11-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 27363726]. |